Troponin I as a Biomarker of Cardiac Injury in Neonates with Idiopathic Respiratory Distress

ABSTRACT

Troponin I (TnI), an inhibitory protein complex located on the actin filament of cardiac muscle, has become a specific marker of myocardial damage. Troponin has been studied in a wide range of clinical settings. However, many questions are still unanswered, especially in preterm neonates with the most common pathology at birth, such as idiopathic respiratory distress syndrome (IRDS). The aim of this study was to establish a reference range for cardiac TnI for healthy preterm infants and serum levels in sick preterm infants with IRDS. Echocardiography was performed and TnI serum levels were measured at a median age of 62 hours of life in three groups of healthy preterm infants (n = 10), and ventilated infants with moderate (n = 15) and severe IRDS (n = 15). Ventilated infants with idiopathic moderate IRDS had significantly different cardiac parameters (R/L ejection fraction, R/L stroke volume, R/L cardiac output; p < 0.05) and significantly higher cardiac TnI levels than healthy infants (0.037 versus 0.01 μg/mL; p < 0.05). Furthermore, infants with severe IRDS had higher TnI concentrations than infants with moderate IRDS (0.26 versus 0.037 μg/mL; p < 0.05). The results of this study show that increased TnI serum levels in sick preterm infants with IRDS are explained by myocardial injury or dysfunction due to impaired arterial oxygenation or reduction in cardiac output during treatment with mechanical ventilation. These results suggest that cardiac TnI may be a useful, specific marker for myocardial damage in preterm neonates with IRDS.

Troponin I - idiopathic respiratory distress (IRDS) - premature infants

REFERENCES

• 1 Hirsch R, Landt Y, Porter S et al.. Cardiac troponin I in pediatrics: normal values and potential use in the assessment of cardiac injury.  J Pediatr. 1997;  130 872-877
• 2 Antman E M, Tanasijevic M J, Thompson B et al.. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndrome.  N Engl J Med. 1996;  335 1342-1349
• 3 Clark S J, Newland P, Yoxall C W, Subhedar N V. Cardiac troponin T in cord blood.  Arch Dis Child Fetal Neonatal Ed. 2001;  84 F34-F37
• 4 Clark S J, Newland P, Yoxall C W, Subhedar N V. Concentrations of cardiac troponin T in neonates with and without respiratory distress.  Arch Dis Child Fetal Neonatal Ed. 2004;  89 F348-F352
• 5 Tiwbin J A. Cardiac troponin I: a new diagnostic gold standard of cardiac injury in children?.  J Pediatr. 1997;  130 853-854
• 6 Moller J C, Thielsen B, Schaible T F et al.. Value of myocardial hypoxia markers (creatine kinase and its MB fraction, troponin T, Q-T intervals) and serum creatinine for the retrospective diagnosis of perinatal asphyxia.  Biol Neonate. 1998;  73 367-374
• 7 Amato M, Gambon R, Howald H, Von Muralt G. Correlation of raised cord-blood CK-BB and the development of peri-intraventricular hemorrhage in preterm infants.  Neuropediatrics. 1986;  17 173-174
• 8 Amato M, Huppi P, Gambon R. Serum creatine-kinase BB concentration in very low birth weight babies with post-hemorrhagic ventricular dilatation.  Brain Dev. 1992;  14 226-229
• 9 Amato M, Donati F. Update on perinatal hypoxic insult: mechanism, diagnosis and interventions.  Eur J Pediatr Neurol. 2000;  4 203-209
• 10 Trevisanuto D, Pitton M, Altinier S et al.. Cardiac troponin I, cardiac troponin T and creatine kinase MB concentrations in umbilical cord blood of healthy term neonates.  Acta Pediatr. 2003;  92 1463-1467
• 11 Horwich T, Patel J, MacLellan R et al.. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction and increased mortality rates in advanced heart failure.  Circulation. 2003;  108 833-838
• 12 Henry W L, De Maria A, Gramiak R et al.. Report of the American Society of Echocardiography on nomenclature and standards in two-dimensional echocardiography.  Circulation. 1980;  62 212-217
• 13 Clark S J, Yoxall C W, Subhedar N V. Measurement of right ventricular volume in healthy term and preterm neonates.  Arch Dis Child Fetal Neonatol Ed. 2002;  87 F89-F94
• 14 Ballard J, Khoury J, Wedig K et al.. New Ballard score, expanded to include extremely premature infants.  J Pediatr. 1991;  119 417-423
• 15 Amato M, Straume B. Iridopupillarmembran zur Bestimmung des Gestationsalters des Fruegeborenen.  Gynaekol Rundsch. 1981;  21 55-58
• 16 Way G L, Pierce J R, Wolfe R R et al.. ST depression suggesting subendocardial ischemia in neonates with respiratory distress syndrome and patent ductus arteriosus.  J Pediatr. 1979;  95 609-611
• 17 Shivvers S, Wians F H, Keffer J H, Ramin S M. Maternal cardiac troponin I levels during normal labor and delivery.  Am J Obstet Gynecol. 1999;  180 122-127
• 18 Engin Y, Ustun Y, Kurtay G. Cardiac troponin I levels in umbilical cord blood.  Int J Gynecol Obstet. 2002;  77 239-241
• 19 Distefano G, Romeo M G, Betta P, Rodono A, Amato M. Thrombomodulin serum levels in ventilated preterm babies with respiratory distress syndrome.  Eur J Pediatr. 1998;  157 327-330
• 20 Trevisanuto D, Zaninotto M, Lachin M et al.. Effect of patent ductus arteriosus and indomethacin treatment on serum cardiac troponin T levels in preterm infants with respiratory distress syndrome.  Eur J Pediatr. 2000;  159 273-276
• 21 Evans N, Kluckow M. Early determinants of right and left ventricular output in ventilated preterm infants.  Arch Dis Child Fetal Neonatal Ed. 1996;  74 F88-F94
• 22 Feng J, Schaus B J, Fallavolita J A et al.. Preload induces troponin I degradation independently of myocardial ischemia.  Circulation. 2001;  103 2935-2037
• 23 Cheng W, Li B, Kajstura J et al.. Stretch-induced programmed myocyte cell death.  J Clin Invest. 1995;  96 2247-2259
• 24 Flynn P A, Da Graca R L, Auld P et al.. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patient ductus arteriosus in premature neonates.  J Pediatr. 2005;  147 38-42